載入...
FROM HOPE TRIAL TO ONTARGET TRIAL: THE «HOPE» TO REACH THE «TARGET» - TO IMPROVE PROGNOSIS IN HIGH RISK PATIENTS
Results of HOPE trial are analyzed. It is noted, that treatment with angiotensine converting enzyme inhibitor (iACE) ramipril improves the prognosis in high risk cardio-vascular patients. The objectives and study design of ONTARGET/TRANSCEND trials are introduced. Perspectives of joint use of ACE in...
Na minha lista:
| 主要作者: | |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Stolichnaya Izdatelskaya Kompaniya
2016-01-01
|
| 叢編: | Racionalʹnaâ Farmakoterapiâ v Kardiologii |
| 主題: | |
| 在線閱讀: | https://www.rpcardio.com/jour/article/view/1052 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|